CCA
OFIX icon

Catalyst Capital Advisors’s Orthofix Medical OFIX Stock Holding History

Catalyst Capital Advisors’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-10,844
Closed -$226K – 296
2013
Q3 		$226K Sell
10,844
-41,947
-79% -$1.02M 0.12% 215
2013
Q2 		$1.42M Buy
+52,791
New +$1.58M 1.1% 10

Other funds holding OFIX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Catalyst Capital Advisors's OFIX Position: Q4 2013 in Review

Catalyst Capital Advisors sold out of Orthofix Medical (OFIX) in Q4 2013, closing a stake of 10,844 shares — an estimated $226K sold.

Catalyst Capital Advisors first reported a position in OFIX in Q2 2013 and held it in 2 quarters. The position peaked at $1.42M in Q2 2013. 100 funds tracked by Wall St. Rank hold OFIX as of Q4 2013.

  • Catalyst Capital Advisors reported no remaining Orthofix Medical position as of Q4 2013 after selling out during the quarter.
  • Catalyst Capital Advisors sold 10,844 Orthofix Medical shares in Q4 2013, an estimated $226K.
  • Catalyst Capital Advisors first reported a position in Orthofix Medical in Q2 2013 and held it in 2 quarters.
  • Catalyst Capital Advisors's Orthofix Medical position peaked at $1.42M in Q2 2013.
  • 100 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2013.

Based on Catalyst Capital Advisors's 13F filing for Q4 2013, filed 13 Feb 2014.